US Archives - Page 36 of 119 - European Medical Journal

Sports Neurology Highlights from the 2025 AAN Annual Meeting

The Annual Meeting of the American Academy of Neurology (AAN) continues to attract neurologists from around the world due to its…

Novel Therapies and Targets for Parkinson’s Disease

In this editorial, the authors highlight newly licensed medications for the symptomatic treatment of Parkinson’s disease (PD) and their…

Brain Injury in Veterans: Outcomes of a 3-Week Interdisciplinary

Military service members and first responders are at elevated risk for TBI. While most individuals with mild TBI report no persisting…

Levetiracetam vs Phenytoin in Brain Injury: Safety and Efficacy Review

New research presented at the American Academy of Neurology (AAN) Annual Meeting 20251 reveals critical insights into the…

The 2024 Revised McDonald Criteria: AAN 2025 Highlights

The 2025 American Academy of Neurology (AAN) Annual Meeting was held in San Diego, California, USA, April 5th–9th, and provided the most…

Seizure Disorders: Clinical Insights and Review of the Major Clinical Topics Impacting the Reproductive Lifespan

The medical management of women with epilepsy is an evolving specialization within neurology and epileptology. This article highlights…

Immunocompromised Patients with Meningitis/Encephalitis: CSF Profile Characterization

There are widely accepted ranges of typical cerebrospinal fluid (CSF) values used to guide diagnosis and treatment of suspected infectious…

What Is Next in Myasthenia Gravis? Insights on Ocular and MuSK Forms from AAN 2025

THE 2025 American Academy of Neurology (AAN) Annual Meeting saw experts in the field travel to San Diego, California, for the field’s…

Cocaine-Induced Leukoencephalopathy: A Case Report

Cocaine-induced leukoencephalopathy is a rare neurological condition usually associated with substances used to adulterate cocaine…

Neurological Complications of Dengue: NEAS Study Results

The global incidence of neurological complications of DENV varies between 5% and 21%. In Colombia, epidemic outbreaks of DENV…